Showing 62,781 - 62,800 results of 63,536 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((ng decrease) OR (nn decrease)) ))', query time: 0.77s Refine Results
  1. 62781

    Fast 3D shape screening of large chemical databases through alignment-recycling-4 by Fabien Fontaine (75372)

    Published 2011
    “…</p><p></p>nimoto equal to 0.73. The quality of the correlation improves as the Transform-Tanimoto threshold is decreased. …”
  2. 62782

    Reduction of apoptotic cells in LIF treated sphere-derived cell cultures 48 h after plating by Kazuo Oshima (36637)

    Published 2011
    “…</p><p></p> Annexin-positive cells and annexin & nestin-double positive cell populations were significantly decreased in response to LIF. Error bars indicate S.E.M., * indicates < 0.05, ** indicates < 0.01, = 4. …”
  3. 62783
  4. 62784

    Abnormal social communication and mounting in Katnal2-KO mice. by Ryeonghwa Kang (6793046)

    Published 2024
    “…Significance is indicated as * (<0.05), ** (<0.01), *** (<0.001) or ns (not significant). …”
  5. 62785

    Table_1_Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis.DOCX by Mariapaola Marino (784475)

    Published 2020
    “…RTX administration was followed by a marked reduction of MuSK Abs at 2–7 months and at 12–30 months (p < 0.02 for MuSK-IgG and p < 0.01 for MuSK-IgG4). …”
  6. 62786

    Mst1<sup>−/−</sup> mice exhibit blunted MOG-specific proliferative and effector cytokine recall responses in vivo. by Konstantin V. Salojin (567844)

    Published 2014
    “…(<b>D</b>) Mice treated with an Mst1 inhibitor exhibit decreased severity of EAE. EAE was induced in C57Bl/6-Albino/129SvEv mice (n = 10 per treatment group) by immunization with MOGp35–55 in CFA and treated twice daily with the indicated doses of the Mst1 inhibitor LP-945706 administered by oral gavage in citrate buffed (pH 4.5, 0.1 M) 1% Tween 80 vehicle, starting one day after the onset of disease in 50% of the animals. …”
  7. 62787

    Figure 4 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition by Hanwei Zhang (19482698)

    Published 2024
    “…The mean of triplicates and representative of three independent experiments, <i>P</i> values indicated. *, <i>P</i> < 0.05; **, <i>P</i> < 0.01; ***, <i>P</i> < 0.001; ****, <i>P</i> < 0.0001. …”
  8. 62788
  9. 62789
  10. 62790
  11. 62791

    Data_Sheet_1_Endotoxemia-Induced Release of Pro-inflammatory Mediators Are Associated With Increased Glomerular Filtration Rate in Humans in vivo.DOCX by Remi Beunders (9604286)

    Published 2020
    “…Mean arterial pressure decreased with 13 ± 11 mmHg (p < 0.0001). No significant increase in the urinary excretion of tubular injury markers was observed following LPS administration. …”
  12. 62792

    Study flow diagram. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  13. 62793

    Forest plot of LVEDD. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  14. 62794

    Risk of bias diagram and summary. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  15. 62795

    Forest plot of NT-pro BNP. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  16. 62796

    Funnel plot of 6-MWT. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  17. 62797

    Forest plot of LVEF. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  18. 62798

    Forest plot of 6-MWT. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  19. 62799

    The incidence rate of adverse events. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”
  20. 62800

    Basic characteristics of included studies. by Lipeng Shi (11307700)

    Published 2023
    “…Meta-analysis indicated that combination medication of pueraria and conventional medicine (CM) was superior to the CM alone in raising left ventricular ejection fraction (LVEF; MD = 6.46, 95% <i>CI</i>, 4.88 to 8.04, <i>P</i> < 0.00001), and decreasing left ventricular end-diastolic diameter (LVEDD; MD = -4.78, 95% <i>CI</i>, -6.55 to -3.01, <i>P</i> < 0.00001), left ventricular end-Systolic diameter (LVESD; MD = -3.98, 95% <i>CI</i>, -5.98 to -1.99, <i>P</i> < 0.00001) and N-terminal pro-brain natriuretic peptide (NT-proBNP; MD = -126.16, 95% <i>CI</i>, -185.30 to -67.03, <i>P</i> < 0.0001). …”